Fulcrum Therapeutics
FULC
#8196
Rank
A$0.29 B
Marketcap
$5.55
Share price
1.13%
Change (1 day)
-48.76%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2023 (TTM): -$2.70

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.80. In 2022 the company made an earnings per share (EPS) of -$3.85 a decrease over its 2021 EPS that were of -$3.56.

EPS history for Fulcrum Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.70-29.86%
2022-$3.858.3%
2021-$3.56-18.51%
2020-$4.37-31.36%
2019-$6.3677.16%
2018-$3.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.39 21.11%๐Ÿ‡บ๐Ÿ‡ธ USA